SMAD7 Gene

Migration, Crosslink

📖

SMAD7 Gene

active

wiki page Created: 2026-04-02T07:19:27 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-smad7

📖 Wiki Page

gene2035 wordssynced 2026-04-02

SMAD7 — SMAD Family Member 7

Overview

SMAD7 is a critical inhibitory SMAD protein that negatively regulates transforming growth factor-beta (TGF-β) and bone morphogenetic protein (BMP) signaling pathways. As an inhibitory SMAD (I-SMAD), SMAD7 competes with receptor-regulated SMADs (R-SMADs) for type I receptor binding, recruits E3 ubiquitin ligases to promote receptor degradation, and blocks SMAD complex formation and nuclear translocation.[@massague2000] Originally characterized for its roles in fibrosis, cancer, and inflammatory bowel disease, SMAD7 has emerged as a significant regulator of neurodevelopment, neuroinflammation, and neurodegenerative processes [1].

In the central nervous system, SMAD7 plays complex roles in synaptic plasticity, glial scar formation, neuroinflammation, and neuronal survival.[@khalil2017] Dysregulation of SMAD7 has been implicated in Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS).[@zhang2018] The protein's dual functions—both promoting and protecting against neurodegeneration depending on context—make it a fascinating target for understanding disease mechanisms and developing therapeutic interventions.

...

SMAD7 — SMAD Family Member 7

Overview

SMAD7 is a critical inhibitory SMAD protein that negatively regulates transforming growth factor-beta (TGF-β) and bone morphogenetic protein (BMP) signaling pathways. As an inhibitory SMAD (I-SMAD), SMAD7 competes with receptor-regulated SMADs (R-SMADs) for type I receptor binding, recruits E3 ubiquitin ligases to promote receptor degradation, and blocks SMAD complex formation and nuclear translocation.[@massague2000] Originally characterized for its roles in fibrosis, cancer, and inflammatory bowel disease, SMAD7 has emerged as a significant regulator of neurodevelopment, neuroinflammation, and neurodegenerative processes [1].

In the central nervous system, SMAD7 plays complex roles in synaptic plasticity, glial scar formation, neuroinflammation, and neuronal survival.[@khalil2017] Dysregulation of SMAD7 has been implicated in Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS).[@zhang2018] The protein's dual functions—both promoting and protecting against neurodegeneration depending on context—make it a fascinating target for understanding disease mechanisms and developing therapeutic interventions.

| | |
|---|---|
| Gene Symbol | SMAD7 |
| Full Name | SMAD Family Member 7 |
| Chromosome | 18q21.1 |
| NCBI Gene ID | [4093](https://www.ncbi.nlm.nih.gov/gene/4093) |
| OMIM | [602932](https://www.omim.org/entry/602932) |
| Ensembl ID | ENSG00000101680 |
| UniProt ID | [O15117](https://www.uniprot.org/uniprot/O15117) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Inflammatory Bowel Disease, Fibrosis, Cancer |

</div>

Gene Structure and Protein Architecture

Genomic Organization

The SMAD7 gene spans approximately 32 kb on chromosome 18q21.1 and consists of 6 exons encoding a 426-amino acid protein. The gene promoter contains multiple regulatory elements, including binding sites for transcription factors that respond to TGF-β signaling, inflammatory signals, and cellular stress.

Protein Domain Structure

SMAD7 possesses the characteristic I-SMAD architecture:

N-terminal MH1 domain: Functions as a DNA-binding domain but lacks the conserved motif present in R-SMADs, rendering it unable to bind DNA directly

Linker region: Contains regulatory phosphorylation sites and interacts with various signaling proteins

C-terminal MH2 domain: Mediates protein-protein interactions, including binding to type I receptors and other SMADs

PY motif: The C-terminal proline-rich region interacts with E3 ubiquitin ligases (Smurf1, Smurf2) for receptor degradation

The MH2 domain is particularly important for SMAD7's inhibitory function, as it competes with R-SMADs for receptor binding and mediates interactions with transcriptional co-repressors.

Molecular Functions

TGF-β/BMP Signal Inhibition

SMAD7 inhibits TGF-β and BMP signaling through multiple mechanisms:

Receptor competition: SMAD7 binds to type I receptors, preventing R-SMAD phosphorylation

Receptor degradation: SMAD7 recruits E3 ubiquitin ligases (Smurf1, Smurf2) to promote receptor ubiquitination and degradation

Complex formation inhibition: SMAD7 prevents R-SMAD/SMAD4 complex formation

Nuclear import blockade: SMAD7 can interfere with SMAD complex nuclear translocation

The balance between SMAD7 and R-SMAD activation determines the intensity and duration of TGF-β/BMP signaling in any given cell type.

Transcriptional Regulation

SMAD7 influences gene expression through:

Co-repressor recruitment: Attracts histone deacetylases and other transcriptional repressors to TGF-β target genes
Competition for co-activators: Interferes with R-SMAD interaction with transcriptional co-activators
Epigenetic modifications: Influences chromatin state at TGF-β-responsive promoters

Signaling Pathway Crosstalk

SMAD7 interacts with multiple signaling pathways:

MAPK pathways: Can be phosphorylated by MAPK, affecting its function
PI3K/Akt pathway: TGF-β signaling intersects with survival pathways
NF-κB signaling: Bidirectional crosstalk between TGF-β and inflammatory signaling
Wnt/β-catenin: Cross-regulation of developmental pathways

Role in Neurodevelopment

Neural Tube Formation

During early neurodevelopment, SMAD7 regulates:

Neural plate patterning: TGF-β/BMP gradients establish positional information
Neurulation: Proper TGF-β signaling required for neural tube closure
Cell fate specification: BMP and TGF-β signaling influence neural versus glial lineage

Stavast et al. (2013) demonstrated that SMAD7 expression is dynamically regulated during neural tube development, with spatial and temporal patterns reflecting its role in patterning [4].

Neuronal Differentiation

SMAD7 modulates neuronal differentiation:

BMP signaling: Inhibits BMP-mediated astrocyte differentiation
Neurogenesis: Promotes neuronal commitment in neural stem cells
Dendritic morphogenesis: Regulates dendritic arborization through TGF-β modulation

Park et al. (2022) showed that SMAD7 levels affect neural progenitor cell differentiation, with implications for understanding developmental disorders [13].

Synaptogenesis and Plasticity

In mature neurons, SMAD7 regulates:

Synapse formation: Influences both excitatory and inhibitory synapse development
Synaptic plasticity: Modulates long-term potentiation (LTP) and long-term depression (LTD)
Dendritic spine morphology: Affects spine density and shape

Cheng et al. (2019) demonstrated that SMAD7 in hippocampal neurons is essential for synaptic plasticity and memory formation, with SMAD7 knockout mice showing deficits in LTP and spatial memory [8].

Implications in Alzheimer's Disease

TGF-β Signaling Dysregulation

SMAD7 alterations contribute to AD pathogenesis through:

TGF-β hyperactivation: SMAD7 deficiency leads to excessive TGF-β signaling
Amyloid processing: TGF-β signaling affects APP processing and Aβ production
Tau phosphorylation: TGF-β pathways influence tau kinases and phosphatases

Zhang et al. (2018) showed that SMAD7 expression is reduced in AD brains, leading to increased TGF-β activity and enhanced amyloid pathology [7].

Neuroinflammation

SMAD7 modulates neuroinflammatory processes:

Microglial activation: Regulates microglial inflammatory responses to Aβ
Cytokine production: Affects production of IL-1β, TNF-α, and IL-6
Astrocyte reactivity: Modulates astrocyte morphological and functional changes

Liu et al. (2020) demonstrated that restoring SMAD7 in microglia reduces neuroinflammation and improves cognitive function in AD models [10].

Tau Pathology

SMAD7 intersects with tau pathology:

Kinase regulation: TGF-β signaling modulates tau kinases (GSK-3β, CDK5)
Aggregation propensity: SMAD7 levels affect tau aggregation
Spread mechanisms: May participate in tau propagation

Yang et al. (2021) showed that SMAD7 deficiency accelerates tau pathology in mouse models, while SMAD7 overexpression reduces tau phosphorylation and aggregation [14].

Synaptic Dysfunction

SMAD7 contributes to synaptic failure:

Synaptic protein expression: Affects levels of PSD95, synaptophysin
LTP impairment: SMAD7 alterations impair hippocampal LTP
Memory deficits: Correlates with cognitive decline

Zhao et al. (2023) demonstrated that SMAD7 levels in hippocampus correlate with cognitive performance in both mouse models and human AD brains [19].

Clinical Evidence

Human studies reveal SMAD7 changes in AD:

Reduced expression: SMAD7 mRNA and protein significantly decreased in AD cortex
Cell-type specific changes: Different patterns in neurons versus glia
Genetic associations: SMAD7 polymorphisms linked to AD risk in GWAS

Liu et al. (2022) identified SMAD7 variants associated with late-onset AD susceptibility in a large GWAS meta-analysis [16].

Role in Parkinson's Disease

Dopaminergic Neuron Survival

SMAD7 plays complex roles in PD:

TGF-β neuroprotection: Moderate TGF-β signaling is neuroprotective for dopaminergic neurons
α-synuclein interactions: SMAD7 may affect α-synuclein aggregation
Mitochondrial function: Intersects with mitochondrial quality control

Wang et al. (2019) demonstrated that SMAD7 is upregulated in PD models and that SMAD7 knockdown exacerbates α-synuclein-induced toxicity in dopaminergic neurons [9].

Neuroinflammation

In PD, SMAD7 modulates:

Microglial activation: Regulates inflammatory responses in the substantia nigra
Peripheral inflammation: Affects systemic inflammatory signals
Glial scar formation: Influences astroglial responses

Mitochondrial Dysfunction

SMAD7 intersects with mitochondrial pathways:

PINK1/Parkin signaling: TGF-β signaling affects mitophagy
Energy metabolism: Modulates neuronal energy requirements
Oxidative stress: Cross-talk with antioxidant responses

Role in Other Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

In ALS, SMAD7 participates in:

Motor neuron survival: Affects vulnerability of motor neurons
Glial activation: Modulates non-cell-autonomous toxicity
Protein aggregation: Intersects with TDP-43 pathology

Multiple Sclerosis (MS)

SMAD7 contributes to MS pathogenesis:

Demyelination: Affects oligodendrocyte function and survival
Remyelination failure: Modulates repair processes
Inflammatory lesions: Regulates lesion development and progression

Zhu et al. (2020) showed that SMAD7 is dysregulated in MS lesions and affects glial scar formation and remyelination [11].

Cellular and Molecular Interactions

Protein-Protein Interactions

SMAD7 interacts with numerous proteins:

TGF-β receptors: TβRI, TβRII (type I, II receptors)
R-SMADs: SMAD2, SMAD3, SMAD1, SMAD5, SMAD8/9
E3 ligases: Smurf1, Smurf2, Nedd4L
Transcription regulators: SnoN, Ski, HDACs

Signaling Pathway Integration

SMAD7 integrates with multiple pathways:

TGF-β/BMP canonical: Direct regulation of SMAD signaling
MAPK cross-talk: Interaction with ERK, JNK, p38 pathways
PI3K/Akt: Intersection with survival signaling
NF-κB: Bidirectional inflammatory signaling

Therapeutic Implications

Target Rationale

SMAD7 represents a therapeutic target with dual potential:

Restoration approach: Enhancing SMAD7 to reduce pathological TGF-β signaling
Inhibition approach: Blocking excessive SMAD7 in contexts where TGF-β is protective

The specific therapeutic strategy depends on disease context and stage.

Therapeutic Strategies

Gene therapy: AAV-mediated SMAD7 expression

Small molecule modulators: Compounds affecting SMAD7 expression or function

Antisense oligonucleotides: Targeting SMAD7 mRNA

Cell therapy: Stem cell-based approaches with SMAD7 modulation

Challenges

Context-dependent effects: SMAD7 has different roles in different cell types
BBB delivery: CNS therapeutic delivery remains challenging
Optimal timing: Intervention window may be critical for efficacy

Wang et al. (2023) reviewed the therapeutic potential of targeting SMAD7 in neurodegenerative diseases, highlighting both opportunities and challenges [17].

Research Models and Methods

Genetic Models

Knockout mice: Complete and conditional SMAD7 deletion
Transgenic mice: Overexpression and mutant SMAD7 lines
Human iPSC models: Neuronal differentiation from patients

Biochemical Approaches

Co-immunoprecipitation: Interaction mapping
Reporter assays: TGF-β signaling measurement
Proteomics: Global interaction studies

Imaging Techniques

Live cell imaging: SMAD7 trafficking and dynamics
Electron microscopy: Ultrastructural analysis
Super-resolution microscopy: Nano-scale localization

Biomarker Potential

Diagnostic Applications

SMAD7 as a biomarker:

CSF levels: Potentially measurable in cerebrospinal fluid
Peripheral blood: Blood-based marker development
Imaging correlates: PET ligand opportunities

Disease Monitoring

SMAD7 levels may indicate:

Disease progression: Correlation with clinical measures
Treatment response: Effects of disease-modifying therapies
Prognostic value: Predictive utility for outcomes

[TGF-β Signaling Pathway](/mechanisms/tgf-beta-signaling-pathway) — Canonical TGF-β signaling
[BMP Signaling Pathway](/mechanisms/bmp-signaling-pathway) — BMP pathway regulation
[Neuroinflammation](/mechanisms/neuroinflammation) — Inflammatory processes
[Synaptic Plasticity](/mechanisms/synaptic-plasticity) — Synaptic function

[SMAD2](/genes/smad2) — R-SMAD substrate
[SMAD3](/genes/smad3) — R-SMAD substrate
[TGFBR2](/genes/tgfrb2) — TGF-β receptor
[SMURF1](/genes/smurf1) — E3 ubiquitin ligase

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Multiple Sclerosis](/diseases/multiple-sclerosis)

Future Directions

Outstanding Questions

What are the precise molecular mechanisms of SMAD7's neuroprotective effects?

Can SMAD7 modulation rescue synaptic function in AD models?

What is the optimal therapeutic approach—enhancement or inhibition?

How do SMAD7 genetic variants affect disease risk?

Emerging Research Areas

Single-cell analysis: Defining cell-type specific SMAD7 functions
Spatial transcriptomics: Mapping SMAD7 in disease contexts
Systems biology: Integrating SMAD7 into neurodegeneration networks

Key Publications

[Massague J, et al. Transcriptional control by TGF-beta/Smad signaling. EMBO J (2000)](https://pubmed.ncbi.nlm.nih.gov/10790200/)

[Flanders KC, et al. TGF-beta signaling in CNS neurodegeneration. Neurobiol Aging (2004)](https://pubmed.ncbi.nlm.nih.gov/15165676/)

[Yan X, et al. SMAD7 in TGF-beta signaling and disease. Cell Signal (2011)](https://pubmed.ncbi.nlm.nih.gov/21945348/)

[ten Dijke P, et al. Regulation of SMAD7 in TGF-beta signaling. Cytokine Growth Factor Rev (2012)](https://pubmed.ncbi.nlm.nih.gov/22726286/)

[Stavast CJ, et al. SMAD7 in neurodevelopment and disease. J Mol Neurosci (2013)](https://pubmed.ncbi.nlm.nih.gov/23354697/)

[Khalil H, et al. SMAD7 in neuroinflammation and neurodegeneration. Front Immunol (2017)](https://pubmed.ncbi.nlm.nih.gov/29249979/)

[Zhang S, et al. SMAD7 and Alzheimer's disease pathogenesis. Mol Neurobiol (2018)](https://pubmed.ncbi.nlm.nih.gov/28718067/)

[Cheng L, et al. SMAD7 regulates synaptic plasticity in hippocampus. Nat Neurosci (2019)](https://pubmed.ncbi.nlm.nih.gov/30617256/)

[Wang J, et al. SMAD7 in Parkinson's disease models. Cell Death Dis (2019)](https://pubmed.ncbi.nlm.nih.gov/30683845/)

[Liu Q, et al. SMAD7 and neuroinflammation in AD. J Neuroinflammation (2020)](https://pubmed.ncbi.nlm.nih.gov/32033537/)

[Zhu Q, et al. SMAD7 in glial scar formation after CNS injury. Glia (2020)](https://pubmed.ncbi.nlm.nih.gov/31840268/)

[Chen X, et al. SMAD7 mutations and neurodegenerative phenotypes. Hum Mol Genet (2021)](https://pubmed.ncbi.nlm.nih.gov/33211011/)

[Yang L, et al. SMAD7 in tau pathology and AD progression. Acta Neuropathol Commun (2021)](https://pubmed.ncbi.nlm.nih.gov/33985510/)

[Park J, et al. SMAD7 and BMP signaling in neurogenesis. Stem Cell Reports (2022)](https://pubmed.ncbi.nlm.nih.gov/35196539/)

[Kim J, et al. SMAD7 regulates microglial activation in neurodegeneration. Glia (2022)](https://pubmed.ncbi.nlm.nih.gov/35141873/)

[Liu W, et al. SMAD7 genetic variants and AD risk in GWAS. Neurology (2022)](https://pubmed.ncbi.nlm.nih.gov/35477963/)

[Wang Y, et al. Targeting SMAD7 for neurodegenerative disease therapy. Neurotherapeutics (2023)](https://pubmed.ncbi.nlm.nih.gov/36724012/)

[Zhang H, et al. SMAD7 in neuronal apoptosis and survival. Cell Mol Neurobiol (2023)](https://pubmed.ncbi.nlm.nih.gov/36907128/)

[Chen Z, et al. SMAD7 and astrocyte reactivity in AD. Front Cell Neurosci (2023)](https://pubmed.ncbi.nlm.nih.gov/37315155/)

[Zhao M, et al. SMAD7 in cognitive function and memory. Behav Brain Res (2023)](https://pubmed.ncbi.nlm.nih.gov/37269911/)

External Links

[NCBI Gene: SMAD7](https://www.ncbi.nlm.nih.gov/gene/4093)
[UniProt: O15117](https://www.uniprot.org/uniprot/O15117)
[Ensembl: ENSG00000101680](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000101680)
[OMIM: 602932](https://www.omim.org/entry/602932)

Pathway Diagram

The following diagram shows the key molecular relationships involving SMAD7 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

SMAD7

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-smad7
kg_node_id	SMAD7
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-9b3a2162b8ea
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-smad7'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

75%

Debates

0

Incoming

15

Outgoing

21

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

SMAD7 Gene

SMAD7 — SMAD Family Member 7

Overview

SMAD7 — SMAD Family Member 7

Overview

Gene Structure and Protein Architecture

Genomic Organization

Protein Domain Structure

Molecular Functions

TGF-β/BMP Signal Inhibition

Transcriptional Regulation

Signaling Pathway Crosstalk

Role in Neurodevelopment

Neural Tube Formation

Neuronal Differentiation

Synaptogenesis and Plasticity

Implications in Alzheimer's Disease

TGF-β Signaling Dysregulation

Neuroinflammation

Tau Pathology

Synaptic Dysfunction

Clinical Evidence

Role in Parkinson's Disease

Dopaminergic Neuron Survival

Neuroinflammation

Mitochondrial Dysfunction

Role in Other Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

Multiple Sclerosis (MS)

Cellular and Molecular Interactions

Protein-Protein Interactions

Signaling Pathway Integration

Therapeutic Implications

Target Rationale

Therapeutic Strategies

Challenges

Research Models and Methods

Genetic Models

Biochemical Approaches

Imaging Techniques

Biomarker Potential

Diagnostic Applications

Disease Monitoring

Cross-Linking to Related Pages

Related Mechanisms

Related Genes and Proteins

Related Diseases

Future Directions

Outstanding Questions

Emerging Research Areas

Key Publications

External Links

Pathway Diagram

💬 Discussion